Trial Profile
A phase I pilot trial to study the safety and efficacy of concomitant radiotherapy and zoledronic acid for the palliation of bone metastases from breast cancer, prostate cancer and lung cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Dec 2010
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Breast cancer; Cancer metastases; Lung cancer; Prostate cancer
- Focus Therapeutic Use
- 20 Dec 2010 Trial phase changed from II to I and actual end date (Mar 2007) added as reported by ClinicalTrials.gov.
- 20 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Aug 2006 New trial record.